Relationships of methacholine and adenosine monophosphate responsiveness with serum vascular endothelial growth factor in children with asthma.
BACKGROUND
Airway hyperresponsiveness, which is a characteristic feature of asthma, is usually measured by means of bronchial challenge with direct or indirect stimuli. Vascular endothelial growth factor (VEGF) increases vascular permeability and angiogenesis, leads to mucosal edema, narrows the airway diameter, and reduces airway flow.


OBJECTIVE
To examine the relationships between serum VEGF level and airway responsiveness to methacholine and adenosine monophosphate (AMP) in children with asthma.


METHODS
Peripheral blood eosinophil counts, serum eosinophil cationic protein (ECP) concentrations, and serum VEGF concentrations were measured in 31 asthmatic children and 26 control subjects. Methacholine and AMP bronchial challenges were performed on children with asthma.


RESULTS
Children with asthma had a significantly higher mean (SD) level of VEGF than controls (361.2 [212.0] vs 102.7 [50.0] pg/mL; P < .001). Blood eosinophil counts and serum ECP levels significantly correlated inversely with AMP provocation concentration that caused a decrease in forced expiratory volume in 1 second of 20% (PC20) (r = -0.474, P =.01; r = -0.442, P =.03, respectively), but not with methacholine PC20 (r = -0.228, P = .26; r = -0.338, P =.10, respectively). Serum VEGF levels significantly correlated with airway responsiveness to AMP (r = -0.462; P = .009) but not to methacholine (r = -0.243; P = .19).


CONCLUSIONS
Serum VEGF levels were increased in children with asthma and were related to airway responsiveness to AMP but not to methacholine. Increased VEGF levels in asthmatic children may result in increased airway responsiveness by mechanisms related to airway inflammation or increased permeability of airway vasculature.
Yoo
Young
Y
Department of Pediatrics, Korea University Anam Hospital, Seoul, Korea.
Choi
Ic Sun
IS
Byeon
Jung Hye
JH
Lee
Seung Min
SM
La
Kyong Suk
KS
Choi
Byung Min
BM
Park
Sang Hee
SH
Choung
Ji Tae
JT
D000249:Adenosine Monophosphate / Q000008:administration & dosage; D001249:Asthma / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology*; D016535:Bronchial Hyperreactivity / Q000097:blood / Q000175:diagnosis* / Q000503:physiopathology*; D001985:Bronchial Provocation Tests; D002452:Cell Count; D002463:Cell Membrane Permeability; D002648:Child; D047150:Eosinophil Cationic Protein / Q000097:blood; D004804:Eosinophils / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D016210:Methacholine Chloride / Q000008:administration & dosage; D012129:Respiratory Function Tests; D042461:Vascular Endothelial Growth Factor A / Q000097:blood*
D042461:Vascular Endothelial Growth Factor A; D016210:Methacholine Chloride; D000249:Adenosine Monophosphate; D047150:Eosinophil Cationic Protein; C479220:RNASE3 protein, human